Global Warming Solutions, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Global Warming Solutions, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | $0 | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | $101.7K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $181.3K | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | $61.9K | Mar 12, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | $0 | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | $28.9K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $48.3K | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | $10.3K | Mar 12, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($516.3K) | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | ($1.28M) | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | ($601.3K) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($886.3K) | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | ($25.6K) | Mar 12, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($427.9K) | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | ($1.24M) | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | ($454.5K) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($848.2K) | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | $3.0K | Mar 12, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $151.0K | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | $574.0K | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | $27.4K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Apr 4, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $109.9K | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | $414.0K | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | $272.7K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.5K | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | $290 | Mar 12, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($586.1K) | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | ($1.31M) | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | ($600.9K) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.0K | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | $12.2K | Mar 12, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Apr 14, 2023 |
| FY2022 | Dec 31, 2021 | $69.0K | Apr 14, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $237.6K | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | $296.3K | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | $993.6K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $76.3K | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | $108.9K | Mar 12, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $352.9K | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | $432.9K | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | $20.3K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $27.5K | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | $555.4K | Mar 12, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($115.3K) | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | ($136.6K) | Jun 24, 2024 |
| FY2023 | Dec 31, 2021 | $973.3K | Jun 24, 2024 |
| FY2022 | Dec 31, 2020 | $48.8K | Apr 14, 2023 |
| FY2021 | Dec 31, 2019 | ($446.5K) | Apr 4, 2022 |
| FY2020 | Dec 31, 2018 | ($388.9K) | Mar 12, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($5.62M) | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | ($5.11M) | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | ($3.83M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($3.23M) | Apr 4, 2022 |
| FY2020 | Dec 31, 2019 | ($2.34M) | Mar 12, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $79 | Apr 14, 2023 |
| FY2022 | Dec 31, 2021 | $840.6K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $12.5K | Apr 4, 2022 |
| FY2021 | Dec 31, 2019 | $11.7K | Apr 4, 2022 |
| FY2020 | Dec 31, 2018 | $0 | Mar 12, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 16.33M | Jun 24, 2024 |
| FY2023 | Dec 31, 2022 | 16.03M | Jun 24, 2024 |
| FY2022 | Dec 31, 2021 | 17.60M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | 24.34M | Apr 4, 2022 |
| FY2020 | Dec 30, 2019 | 29.41M | Mar 12, 2021 |